Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients. The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world. Read More
Artificial intelligence is rapidly transforming America's healthcare system, offering immediate and profound benefits across the entire spectrum of care, from individual patients to providers and public health initiatives. For patients, AI is leading to earlier, more accurate diagnoses and highly personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, including imaging [...]
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's stronger-than-expected second-quarter fiscal 2026 earnings report, which showcased robust performance driven by key segments and innovative technology.
Medtronic PLC's stock rose on strong Q2 results, driven by high demand in cardiovascular and diabetes businesses. Analysts maintain Hold and Neutral ratings.
December Nasdaq 100 E-Mini futures (NQZ25) are trending up +0.44% this morning, signaling a modest rebound from a bruising stretch of losses, while investors look ahead to an earnings report from AI darling Nvidia.
As broader markets grapple with persistent volatility on November 18, 2025, the healthcare sector within the S&P 500 (SPX) finds itself under intense scrutiny. Traditionally viewed as a stalwart defensive play, its performance today is crucial for understanding prevailing market sentiment. Is the sector merely living up to its
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Medtronic beats Q2 FY26 earnings and revenue estimates, driven by 71% growth in its Cardiac Ablation Solutions business. The company also raised its full-year guidance.
